| |
| |
| |
| ● |
Ongoing development of R&D pipeline
|
| ● |
Strong continued growth of OTC franchise
|
| ● |
Successful 2013 National Kickoff Meeting in Shanghai with CEO and commercial Director of Gedeon Richter
|
| ● |
Rxmidas/GRmidas local sales increased 50% against 2011
|
| ● |
Rxmidas and Gedeon Richter form a new powerful JV in China
|